Ectasia
19
2
2
7
Key Insights
Highlights
Success Rate
64% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 64/100
21.1%
4 terminated out of 19 trials
63.6%
-22.9% vs benchmark
21%
4 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (19)
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
The Italian Coronary Artery Aneurysm and Ectasia In Patients With Acute Coronary Syndrome
Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management
Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting
Progressive Keratoconus or Ectasia Treatment Plan
Higher Irradiance in Keratoconus Ectasia
Safety Study of the VEGA UV-A System to Treat Ectasia
Corneal Collagen Cross-Linking for Ectasia (CXL)
Corneal Collagen Cross-Linking (CXL) Performed With "Epi-ON" Versus "Epi-OFF" in Eyes With Keratoconus and Other Corneal Ectatic Disorders
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs
Safety and Effectiveness of Corneal Crosslinking (CXL): Keratoconus and Post-Refractive Ectasia
Eye Rubbing and Transient Change in Corneal Parameters
Intrastromal Corneal Ring for Ectasia After Refractive Surgery (Anel)
Laser Treatment Of Vascular Lesions On Vocal Cords
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia